Taken together, our findings indicate that, while dysregulated IL-17a contributes to pathology in autoimmune diseases such as psoriasis or arthritis in humans, in canine leishmaniosis, IL-17a may serve a protective role in promoting an effective immune response. Here, IL17A is linked to autoimmune disease.